Abstract
Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide. Until now its exact pathogenesis and etiology are not clear. So far there is no approved therapy. New approaches for RP therapy include cell transplantation, gene therapy, cytokine therapy, nutrition therapy, and hyperbaric oxygen therapy. Such therapies for retinal degenerative diseases are limited in their efficacy. This paper reviews the relevant documents, especially recent researches, and reviews advances in the treatment of RP.
Keywords: Cell transplantation, cytokine therapy, gene therapy, hyperbaric oxygen therapy, nutrition therapy, retinitis pigmentosa.
Current Stem Cell Research & Therapy
Title:Recent Advances in Treatment of Retinitis Pigmentosa
Volume: 10 Issue: 3
Author(s): Yuxi He, Yan Zhang and Guanfang Su
Affiliation:
Keywords: Cell transplantation, cytokine therapy, gene therapy, hyperbaric oxygen therapy, nutrition therapy, retinitis pigmentosa.
Abstract: Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide. Until now its exact pathogenesis and etiology are not clear. So far there is no approved therapy. New approaches for RP therapy include cell transplantation, gene therapy, cytokine therapy, nutrition therapy, and hyperbaric oxygen therapy. Such therapies for retinal degenerative diseases are limited in their efficacy. This paper reviews the relevant documents, especially recent researches, and reviews advances in the treatment of RP.
Export Options
About this article
Cite this article as:
He Yuxi, Zhang Yan and Su Guanfang, Recent Advances in Treatment of Retinitis Pigmentosa, Current Stem Cell Research & Therapy 2015; 10 (3) . https://dx.doi.org/10.2174/1574888X09666141027103552
DOI https://dx.doi.org/10.2174/1574888X09666141027103552 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial: Glia-Neuron Crosstalk and its Therapeutic Implication in Neuropsychiatric Disorders
Current Neuropharmacology Phenotype Data: A Neglected Resource in Biomedical Research?
Current Bioinformatics Longevity Pathways: HSF1 and FoxO Pathways, a New Therapeutic Target to Prevent Age-Related Diseases
Current Aging Science Current Trends in the Management of Infected Necrotizing Pancreatitis
Infectious Disorders - Drug Targets Treatment of MDR1 Mutant Dogs with Macrocyclic Lactones
Current Pharmaceutical Biotechnology Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19
Protein & Peptide Letters Patent Selections
Recent Patents on Cardiovascular Drug Discovery The MicroRNA Days: The COVID-19 Pandemic from the Point of View of Short RNAs
MicroRNA Postischemic-Anoxic Encephalopathy After Global Forebrain Ischemia
Central Nervous System Agents in Medicinal Chemistry Intracellular Drug Delivery: Mechanisms for Cell Entry
Current Pharmaceutical Design Editorial from Editorial Board Member [ Thoughts on Impact Factors and Editing of Medical Journals ]
Inflammation & Allergy - Drug Targets (Discontinued) Review Metabolomics: A New Approach to Drug Delivery in Perinatology
Current Medicinal Chemistry The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis
Current Signal Transduction Therapy Cytoskeletal Alterations that Confer Resistance to Anti-tubulin Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors-Considerations for Successful Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry Mechanism(s) Involved in Opioid Drug Abuse Modulation of HAND
Current HIV Research Macrolide Therapy Targets a Specific Phenotype in Respiratory Medicine: From Clinical Experience to Basic Science and Back
Inflammation & Allergy - Drug Targets (Discontinued) When Neighbors Talk: Colon Cancer Cell Invasion and Tumor Microenvironment Myofibroblasts
Current Drug Targets Differential Gene Expression of <i>ASUN, NEMF, PTPRC</i> and <i>DHX29</i>: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis
Infectious Disorders - Drug Targets